Georg Tschank
37Patents
11h-index
36Co-inventors
75Inventor score
Filing activity: Aug 29, 1985 → Mar 7, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6093730A | Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals | Human Necessities | 114 | Expired |
| US5620995A | Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 107 | Expired |
| US5658933A | Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 94 | Expired |
| US5719164A | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | Chemistry; Metallurgy | 91 | Expired |
| US6020350A | 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals | Human Necessities | 59 | Expired |
| US5726305A | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | Chemistry; Metallurgy | 59 | Expired |
| US4717727A | Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments for the inhibition of proline hydroxylase and lysine hydroxylase | Chemistry; Metallurgy | 30 | Expired |
| US7094800B2 | Cyanopyrrolidides, process for their preparation and their use as medicaments | Chemistry; Metallurgy | 17 | Expired |
| US8633156B2 | Insulin derivatives having an extremely delayed time-action profile | Human Necessities | 17 | Active |
| US7008957B2 | Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments | Chemistry; Metallurgy | 16 | Expired |
| US5037839A | Pyridine-2,4-and -2,5-dicarboxylic acid amides and medicaments based on these compounds | Chemistry; Metallurgy | 14 | Expired |
| US8828994B2 | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof | Chemistry; Metallurgy | 4 | Active |
| US8003668B2 | Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders | Human Necessities | 4 | Active |
| US5153208A | Pyridine-2,4- and -2,5-dicarboxylic acid amides and their medicinal compositions and methods of use | Chemistry; Metallurgy | 3 | Expired |
| US8138207B2 | Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositions | Human Necessities | 2 | Active |
| US7569700B2 | Substituted, bicyclic 8-pyrrolidinobenzimidazoles, methods for their production and their use as medicaments | Human Necessities | 2 | Active |
| US8163774B2 | Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicaments | Chemistry; Metallurgy | 1 | Active |
| US7888343B2 | Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase | Human Necessities | 1 | Active |
| US8809325B2 | Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof | Chemistry; Metallurgy | 0 | Active |
| US8901114B2 | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US7629126B2 | PIM-3 kinase as a target for type 2 diabetes mellitus | Chemistry; Metallurgy | 0 | Active |
| US5512586A | Medicaments based on pyridine-2,4- and 2,5-dicarboxylic acid amides | Chemistry; Metallurgy | 0 | Expired |
| US8809324B2 | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof | Chemistry; Metallurgy | 0 | Active |
| US8895547B2 | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof | Chemistry; Metallurgy | 0 | Active |
| US7227006B2 | PIM-3 kinase as a target for type 2 diabetes mellitus | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.